Historial de carrera de Lyndsey Scull
Antiguos cargos conocidos de Lyndsey Scull.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MAGENTA THERAPEUTICS | Contacto de Relaciones con Inversores | 01/12/2019 | 01/10/2021 |
| Public Communications Contact | 01/12/2019 | 01/10/2021 |
Estadísticas
Internacional
| Estados Unidos | 2 |
Operativa
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sectorial
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Lyndsey Scull
- Experiencia
